FDA Inspection 737804 — Brigham And Women's Hospital

Brigham And Women's Hospital — FEI 1270016

The FDA completed an inspection of Brigham And Women's Hospital on August 4, 2011 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 4, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)